Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q38072907)
Watch
English
The 2011 Gordon Wilson Lecture: overcoming resistance to targeted cancer drugs.
scientific article published on January 2012
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
3540597
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23303979%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
title
The 2011 Gordon Wilson Lecture: overcoming resistance to targeted cancer drugs
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3540597
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23303979%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
author name string
Charles L Sawyers
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3540597
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23303979%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
publication date
1 January 2012
1 reference
stated in
Europe PubMed Central
PMC publication ID
3540597
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23303979%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
published in
Transactions of the American Clinical and Climatological Association
1 reference
stated in
Europe PubMed Central
PMC publication ID
3540597
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23303979%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
volume
123
1 reference
stated in
Europe PubMed Central
PMC publication ID
3540597
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23303979%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
page(s)
114-23; discussion 123-5
1 reference
stated in
Europe PubMed Central
PMC publication ID
3540597
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23303979%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
cites work
ARN-509: a novel antiandrogen for prostate cancer treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Abiraterone and increased survival in metastatic prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Development of a second-generation antiandrogen for treatment of advanced prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Overriding imatinib resistance with a novel ABL kinase inhibitor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Molecular determinants of resistance to antiandrogen therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
6 September 2017
FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
14 September 2017
Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3540597
retrieved
31 August 2018
Identifiers
PMC publication ID
3540597
1 reference
stated in
Europe PubMed Central
PMC publication ID
3540597
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23303979%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
PubMed publication ID
23303979
1 reference
stated in
Europe PubMed Central
PMC publication ID
3540597
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23303979%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
